OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation.

TitleOCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation.
Publication TypeJournal Article
Year of Publication2016
AuthorsSimandi Z, Horvath A, Wright LC, Cuaranta-Monroy I, De Luca I, Karolyi K, Sauer S, Deleuze J-F, Gudas LJ, Cowley SM, Nagy L
JournalMol Cell
Volume63
Issue4
Pagination647-661
Date Published2016 08 18
ISSN1097-4164
KeywordsAnimals, Binding Sites, Cell Differentiation, Cell Lineage, Cellular Reprogramming, Embryonic Stem Cells, Gene Expression Regulation, HEK293 Cells, Homeodomain Proteins, Humans, Mice, Octamer Transcription Factor-3, Pluripotent Stem Cells, Promoter Regions, Genetic, Retinoic Acid Receptor alpha, Retinoid X Receptors, RNA Interference, Transcription, Genetic, Transfection, Tretinoin, Wnt Signaling Pathway
Abstract

Cell type specification relies on the capacity of undifferentiated cells to properly respond to specific differentiation-inducing signals. Using genomic approaches along with loss- and gain-of-function genetic models, we identified OCT4-dependent mechanisms that provide embryonic stem cells with the means to customize their response to external cues. OCT4 binds a large set of low-accessible genomic regions. At these sites, OCT4 is required for proper enhancer and gene activation by recruiting co-regulators and RAR:RXR or β-catenin, suggesting an unexpected collaboration between the lineage-determining transcription factor and these differentiation-initiating, signal-dependent transcription factors. As a proof of concept, we demonstrate that overexpression of OCT4 in a kidney cell line is sufficient for signal-dependent activation of otherwise unresponsive genes in these cells. Our results uncover OCT4 as an integral and necessary component of signal-regulated transcriptional processes required for tissue-specific responses.

DOI10.1016/j.molcel.2016.06.039
Alternate JournalMol. Cell
PubMed ID27499297
Grant ListG0600135 / / Medical Research Council / United Kingdom
R01 CA043796 / CA / NCI NIH HHS / United States
MR/J009202/1 / / Medical Research Council / United Kingdom
/ / Biotechnology and Biological Sciences Research Council / United Kingdom